79898-08-1

Basic information

• Product Name: (3S)-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-(4-methoxypiperidin-1-yl)-alpha-L-lyxo-hexopyranoside hydrochloride (1:1)
• CAS NO: 79898-08-1
• Molecular Formula: C₃₃H₄₂ClNO₁₁
• Molecular Weight: 664.1397
• Mol File: 79898-08-1.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 807.8°C at 760 mmHg
• Flash Point: 442.3°C
• Vapor Pressure: 1.47E-27mmHg at 25°C
• CAS DataBase Reference: (3S)-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-(4-methoxypiperidin-1-yl)-alpha-L-lyxo-hexopyranoside hydrochloride (1:1)(CAS DataBase Reference)
• NIST Chemistry Reference: (3S)-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-(4-methoxypiperidin-1-yl)-alpha-L-lyxo-hexopyranoside hydrochloride (1:1)(79898-08-1)
• EPA Substance Registry System: (3S)-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-(4-methoxypiperidin-1-yl)-alpha-L-lyxo-hexopyranoside hydrochloride (1:1)(79898-08-1)

Safety Data

• Hazardous Substances Data: 79898-08-1(Hazardous Substances Data)

Usage

Description

(3S)-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-(4-methoxypiperidin-1-yl)-alpha-L-lyxo-hexopyranoside hydrochloride (1:1) is a complex chemical compound that combines a tetracycline antibiotic with a sugar molecule. The tetracycline component exhibits broad-spectrum antimicrobial properties, while the sugar molecule is believed to influence the drug's pharmacokinetics and pharmacodynamics. The hydrochloride salt form enhances the compound's solubility and stability, making it a candidate for pharmaceutical applications, particularly in the treatment of bacterial infections.

Uses

Used in Pharmaceutical Industry:
(3S)-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-(4-methoxypiperidin-1-yl)-alpha-L-lyxo-hexopyranoside hydrochloride (1:1) is used as an antimicrobial agent for the treatment of various bacterial infections. Its broad-spectrum activity and improved solubility due to the hydrochloride salt form make it a promising candidate for pharmaceutical development.
Used in Research and Development:
In the field of medical research, this compound can be used as a starting point for the development of new antibiotics or for studying the mechanisms of action of tetracycline antibiotics and their interactions with bacterial cells. (3S)-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-(4-methoxypiperidin-1-yl)-alpha-L-lyxo-hexopyranoside hydrochloride (1:1)'s unique structure may also provide insights into the design of novel drugs with enhanced properties or reduced side effects.
Used in Drug Delivery Systems:
Similar to other complex chemical compounds with pharmaceutical potential, (3S)-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-(4-methoxypiperidin-1-yl)-alpha-L-lyxo-hexopyranoside hydrochloride (1:1) could be employed in the development of targeted drug delivery systems. These systems could improve the compound's bioavailability, reduce side effects, and enhance its therapeutic efficacy.